Lundbeck sees healthcare sector exhibiting resilience

Deborah Dunsire, president and CEO of multinational pharmaceutical company Lundbeck A/S, expects more business opportunities to unfold rapidly in China, the second-largest market for the company.

"As the government focuses on expanding healthcare and introducing more primary care in rural areas, and access to innovation, we feel we are a great fit for China," she said.

A world player in psychiatric and neurological disorders, the Copenhagen-headquartered company launched its first drug in the China market through cooperation with local partners in the late 1990s, for the treatment of mild to moderate depression and anxiety.